| 000 | 00883 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518095637.0 | ||
| 264 | 0 | _c20201005 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1759-4782 | ||
| 024 | 7 |
_a10.1038/s41571-020-0369-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRomero, Diana | |
| 245 | 0 | 0 |
_aBenefit from pemigatinib in cholangiocarcinoma. _h[electronic resource] |
| 260 |
_bNature reviews. Clinical oncology _c06 2020 |
||
| 300 |
_a337 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aBile Duct Neoplasms |
| 650 | 0 | 4 | _aBile Ducts, Intrahepatic |
| 650 | 0 | 4 | _aCholangiocarcinoma |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 773 | 0 |
_tNature reviews. Clinical oncology _gvol. 17 _gno. 6 _gp. 337 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41571-020-0369-z _zAvailable from publisher's website |
| 999 |
_c30867063 _d30867063 |
||